| | 108319-06-8 Basic information More.. |
| Product Name: | TEMAFLOXACIN | | Synonyms: | Teflox;6-Fluoro-1-(2,4-difluorophenyl)-7-(3-methylpiperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid;TeMafloxacin HCl;TEMAFLOXACIN;AKOS 92085;1-(2,4-Difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl) -4-oxo-3-quinoline-carboxylic acid;1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quino line-3-carboxylic acid hydrochloride;A-62254 | | CAS: | 108319-06-8 | | MF: | C21H18F3N3O3 | | MW: | 417.38 | | EINECS: | | | Mol File: | 108319-06-8.mol |  |
Use
Temafloxacin, a quinolone antimicrobial, was introduced in 1991.
Shortly afterwards, its use became associated with severe adverse effects,
including hypoglycaemia, haemolytic anaemia, renal failure, hepatitis and
anaphylactic reactions. This led to its worldwide withdrawal by the manufacturer.
- Temafloxacin
-
- US $34.00-80.00 / mg
- 2025-10-26
- CAS:108319-06-8
- Min. Order:
- Purity: 99.24%
- Supply Ability: 10g
- TEMAFLOXACIN USP/EP/BP
-
- US $1.10 / g
- 2021-07-20
- CAS:108319-06-8
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
|
108319-06-8
Recommend Suppliers |
|